MX2024006051A - Nuevos andamios de proteinas tale con relaciones de actividad en objetivo/fuera de objetivo mejoradas. - Google Patents
Nuevos andamios de proteinas tale con relaciones de actividad en objetivo/fuera de objetivo mejoradas.Info
- Publication number
- MX2024006051A MX2024006051A MX2024006051A MX2024006051A MX2024006051A MX 2024006051 A MX2024006051 A MX 2024006051A MX 2024006051 A MX2024006051 A MX 2024006051A MX 2024006051 A MX2024006051 A MX 2024006051A MX 2024006051 A MX2024006051 A MX 2024006051A
- Authority
- MX
- Mexico
- Prior art keywords
- target
- improved
- activity ratios
- tale protein
- tale
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/102—Mutagenizing nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
- C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
- C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/09—Fusion polypeptide containing a localisation/targetting motif containing a nuclear localisation signal
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Cell Biology (AREA)
- Mycology (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163282453P | 2021-11-23 | 2021-11-23 | |
| DKPA202270104 | 2022-03-15 | ||
| PCT/EP2022/082950 WO2023094435A1 (en) | 2021-11-23 | 2022-11-23 | New tale protein scaffolds with improved on-target/off-target activity ratios |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2024006051A true MX2024006051A (es) | 2024-06-26 |
Family
ID=84487474
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2024006051A MX2024006051A (es) | 2021-11-23 | 2022-11-23 | Nuevos andamios de proteinas tale con relaciones de actividad en objetivo/fuera de objetivo mejoradas. |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250002945A1 (enExample) |
| EP (1) | EP4437091A1 (enExample) |
| JP (1) | JP2024540639A (enExample) |
| KR (1) | KR20240110844A (enExample) |
| AU (1) | AU2022395500A1 (enExample) |
| CA (1) | CA3238700A1 (enExample) |
| IL (1) | IL312721A (enExample) |
| MX (1) | MX2024006051A (enExample) |
| WO (1) | WO2023094435A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4583890A1 (en) * | 2022-09-09 | 2025-07-16 | Iovance Biotherapeutics, Inc. | Processes for generating til products using pd-1/tigit talen double knockdown |
| WO2025181336A1 (en) | 2024-03-01 | 2025-09-04 | Cellectis Sa | Compositions and methods for hbb-editing in hspc |
| KR20250148471A (ko) * | 2024-04-02 | 2025-10-14 | 재단법인 아산사회복지재단 | 핵산 결합 단백질 및 SsdA를 포함하는 융합단백질 및 이의 용도 |
| WO2026046724A1 (en) | 2024-08-30 | 2026-03-05 | Cellectis Sa | Tale protein scaffolds involving fusions of monopartite and bipartite nls |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4880635B1 (en) | 1984-08-08 | 1996-07-02 | Liposome Company | Dehydrated liposomes |
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| US4921757A (en) | 1985-04-26 | 1990-05-01 | Massachusetts Institute Of Technology | System for delayed and pulsed release of biologically active substances |
| US4920016A (en) | 1986-12-24 | 1990-04-24 | Linear Technology, Inc. | Liposomes with enhanced circulation time |
| JPH0825869B2 (ja) | 1987-02-09 | 1996-03-13 | 株式会社ビタミン研究所 | 抗腫瘍剤包埋リポソ−ム製剤 |
| US4911928A (en) | 1987-03-13 | 1990-03-27 | Micro-Pak, Inc. | Paucilamellar lipid vesicles |
| US4917951A (en) | 1987-07-28 | 1990-04-17 | Micro-Pak, Inc. | Lipid vesicles formed of surfactants and steroids |
| PT2816112T (pt) | 2009-12-10 | 2018-11-20 | Univ Iowa State Res Found Inc | Modificação do adn modificada pelo efector tal |
| US20140115726A1 (en) | 2011-04-05 | 2014-04-24 | Cellectis | New tale-protein scaffolds and uses thereof |
| EP2737066B1 (en) | 2011-07-29 | 2017-11-08 | Cellectis | High throughput method for assembly and cloning polynucleotides comprising highly similar polynucleotidic modules |
| SG10201806573TA (en) | 2012-05-25 | 2018-09-27 | Cellectis | Methods for engineering allogeneic and immunosuppressive resistant t cell for immunotherapy |
| US10378007B2 (en) * | 2012-09-03 | 2019-08-13 | Cellectis | Methods for modulating TAL specificity |
| CA2913872C (en) | 2013-05-31 | 2022-01-18 | Cellectis | A laglidadg homing endonuclease cleaving the t-cell receptor alpha gene and uses thereof |
-
2022
- 2022-11-23 IL IL312721A patent/IL312721A/en unknown
- 2022-11-23 EP EP22821976.2A patent/EP4437091A1/en active Pending
- 2022-11-23 JP JP2024530470A patent/JP2024540639A/ja active Pending
- 2022-11-23 US US18/712,640 patent/US20250002945A1/en active Pending
- 2022-11-23 MX MX2024006051A patent/MX2024006051A/es unknown
- 2022-11-23 AU AU2022395500A patent/AU2022395500A1/en active Pending
- 2022-11-23 KR KR1020247020471A patent/KR20240110844A/ko active Pending
- 2022-11-23 WO PCT/EP2022/082950 patent/WO2023094435A1/en not_active Ceased
- 2022-11-23 CA CA3238700A patent/CA3238700A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP4437091A1 (en) | 2024-10-02 |
| WO2023094435A1 (en) | 2023-06-01 |
| CA3238700A1 (en) | 2022-11-23 |
| IL312721A (en) | 2024-07-01 |
| US20250002945A1 (en) | 2025-01-02 |
| AU2022395500A1 (en) | 2024-05-23 |
| KR20240110844A (ko) | 2024-07-16 |
| JP2024540639A (ja) | 2024-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Heidorn et al. | Synthetic biology in cyanobacteria: engineering and analyzing novel functions | |
| CO2018006699A2 (es) | Métodos escalables para producir un vector viral adenoasociado (aav) recombinante en un sistema de cultivo celular en suspensión sin suero adecuado para uso clínico | |
| BR112013007862A2 (pt) | ácidos nucleicos manipulados e métodos de uso dos mesmos. | |
| AR117697A2 (es) | Medios de cultivo celular | |
| MX2021006741A (es) | Ingenieria del genoma humano guiada por acido ribonucleico. | |
| BR112014030007A2 (pt) | minivetores superenrolados como uma ferramenta para reparação, alteração e substituição de dna | |
| MX2020013384A (es) | Compuestos de comarina sustituidos con amina exocíclica y sus usos como etiquetas fluorescentes. | |
| MX2012013037A (es) | Composiciones de endorribonucleasa y metodos de uso de las mismas. | |
| IL287089B1 (en) | Integration of nucleic acid constructs into eukaryotic cells with a transposase from oryzias | |
| AR073602A1 (es) | Metodo para producir un aditivo para la degradacion enzimatica de micotoxinas y aditivo y uso del mismo | |
| PY2055454A (es) | Polipéptidos que poseen actividad de beta-glucanasa y polinucleótidos que los codifican | |
| BR112014029441A2 (pt) | rna tendo como alvo dna; polinucleotídeo de dna; vetor de expressão recombinante; célula hospedeira geneticamente modificada in vitro; polipeptídeo de modificação dirigido a sítio variante; polipeptídeo de modificação dirigido a sítio quimérico; polinucleotídeo de rna; célula modificada geneticamente; organismo não humano transgênico cujo genoma compreende um transgene; composição; método de modificação específica de sítio de um dna de alvo; método de modulação de transcrição específica de sítio dentro de um dna de alvo; método de modificação específica de sítio em dna de alvo; método de promover clivagem e modificação específica de sítio de um dna de alvo em uma célula; método de produzir uma célula modificada geneticamente em um sujeito; método de modificar dna de alvo em uma célula modificada geneticamente; kit; kit para direcionar dna de alvo; método de modular seletivamente transcrição de um dna de alvo em uma célula hospedeira; ácido nucleico isolado; célula hospedeira modificada geneticamente; e biblioteca de ácidos nucleicos | |
| MX2021014054A (es) | Metodos y celulas para la produccion microbiana de fitocannabinoides y precursores de fitocannabinoides. | |
| BR112013002811A8 (pt) | meios básicos simplificados para cultura celular pluripotente de humano | |
| BR112012017267A2 (pt) | ácidos graxos de cadeia ramificada dispersos e produção biológica dos mesmos | |
| RU2014149120A (ru) | Способы и композиции для опосредованной нуклеазой направленной интеграции трансгенов | |
| BR112019006388A2 (pt) | enzimas modificadoras de ácido nucleico guiadas por rna e métodos de uso das mesmas | |
| AR086995A1 (es) | Metodos y composiciones para producir plantas con esterilidad masculina | |
| MX354267B (es) | Nucléosidos, nucleótidos, y ácidos nucleicos modificados, y usos de los mismos. | |
| PY2110525A (es) | Polipéptidos con actividad de alfa amilasa y polinucleótidos que los codifican | |
| UY35019A (es) | Loci de performance de fad3 y proteínas de unión específicas de un sitio objetivo correspondiente capaces de inducir rupturas direccionadas | |
| BR112019005270A2 (pt) | produção heteróloga de ácido 10-metilesteárico | |
| UY35020A (es) | Desempeño de ubicación de fad2 y su correspondiente sitio de incidencia específica de las proteínas de unión capaces de inducir rupturas ya seleccionadas. | |
| AR072531A1 (es) | SENAL DE POLIADENILACIoN | |
| EA201270224A1 (ru) | Среда для культивирования клеток для экспрессии белков adamts |